Equate Menthol Pain Relieving

Description

Equate Menthol Pain Relieving Patch is a topical analgesic formulation designed to provide localized pain relief. The patch contains menthol as its active ingredient, which acts as a counterirritant to alleviate discomfort. The product is presented in a convenient adhesive patch dosage form, allowing for easy application to the affected area. The patch is characterized by its translucent appearance, facilitating discreet use.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older should apply the patch to the affected area, with a recommended frequency of changing the patch 1 to 2 times daily. For children under 12 years of age, it is advised to consult a physician prior to use.

For optimal results, the patch should be applied to clean, dry skin. To prepare the patch for application, the healthcare professional should tear open the pouch and remove the patch. If necessary, the patch may be cut to the desired size.

To apply the patch, the user should grasp both ends firmly with their thumbs near the center and stretch the patch until the backing separates. The protective film should then be removed while applying the patch directly to the site of pain.

Contraindications

The product is contraindicated for application to wounds, damaged skin, or very sensitive skin due to the potential for exacerbating irritation or causing adverse reactions. Additionally, it should not be used with tight bandaging or in conjunction with heating pads, as these practices may increase the risk of skin irritation or other complications.

Patients should discontinue use and consult a healthcare professional if the condition worsens, if excessive redness, irritation, burning, or discomfort occurs, or if symptoms persist for more than 7 days or recur shortly after resolution.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to use the product strictly as directed to ensure safety and efficacy. It is imperative to avoid contact with the eyes and mucous membranes, as such contact may lead to irritation or adverse effects. Additionally, the product should not be applied to wounds, damaged skin, or areas of very sensitive skin to prevent further complications.

When administering this product, it is crucial to avoid tight bandaging or the use of heating pads, as these practices may exacerbate skin reactions or interfere with the product's intended effects.

Patients should be instructed to discontinue use and consult a healthcare provider if any of the following occur: worsening of the condition, excessive redness, irritation, burning, or discomfort of the skin. Furthermore, if symptoms persist for more than 7 days or if they resolve and then recur within a few days, medical advice should be sought.

In the event of accidental ingestion, immediate medical assistance should be obtained, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience adverse reactions, which can vary in severity. It is important to note that this product is for external use only and should be applied strictly as directed.

Common adverse reactions include excessive redness, irritation, burning, or discomfort of the skin. If any of these symptoms develop, patients are advised to stop use and consult a healthcare professional. Additionally, if the condition worsens or symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, medical advice should be sought.

Patients should also be cautious to avoid contact with eyes and mucous membranes, and the product should not be applied to wounds, damaged skin, or very sensitive areas. Bandaging tightly or using the product in conjunction with a heating pad is not recommended, as this may exacerbate adverse reactions.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Menthol Pain Relieving (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and adults aged 12 years and older, the recommended application is to the affected area, with the patch being changed 1 to 2 times daily.

It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of EQUATE MENTHOL PAIN RELIEVING menthol patch during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks versus benefits before recommending this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and individualized patient assessment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to stop using the product and consult a doctor if their condition worsens, if they experience excessive redness, irritation, burning, or discomfort of the skin, or if symptoms persist for more than 7 days or clear up and then recur within a few days.

When using this product, patients must be reminded to use it only as directed. They should avoid contact with the eyes and mucous membranes, and not apply the product to wounds or to damaged or very sensitive skin. Additionally, patients should be cautioned against bandaging the area tightly or using it in conjunction with a heating pad.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at room temperature, ensuring that it is protected from light exposure. Freezing the product is not permitted, as it may compromise its integrity. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically. For adults and children aged 12 years and older, the patch should be applied to the affected area and changed 1 to 2 times daily. For children under 12 years, it is advised to consult a doctor before use. No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Equate Menthol Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)